Business Standard

Torrent Pharma posts Q4FY20 PBT of Rs 293 cr, consolidated revenue up 4.69%

The company saw its total consolidated revenue in Q4FY20 at Rs 1961 crore, up by a marginal 4.69 per cent over Rs 1873 crore in Q4FY19

pharma, medicines, drugs
Premium

Brazil market saw constant currency sales grow by 11 per cent to R$119 million, driven by new launches and market share gain

Vinay Umarji Ahmedabad
On the back of the synergies of the acquired Unichem portfolio, drug maker Torrent Pharmaceuticals Ltd posted a consolidated profit before tax (PBT) of Rs 293 crore for the quarter ended March 30, 2020. In Q4FY19, the company had posted a consolidated loss before tax of Rs 150 crore.

The company saw its total consolidated revenue in Q4FY20 at Rs 1961 crore, up by a marginal 4.69 per cent over Rs 1873 crore in Q4FY19. For the full financial year, while Torrent Pharma posted an over 110 per cent growth in its consolidated PBT at Rs 1187 crore in FY20, up

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 26 2020 | 8:23 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com